Here is a focused summary of torsemide infusion dosing from authoritative sources:
Torsemide IV Infusion Dosing
When to Use Infusion vs. Bolus
Torsemide is most commonly given as IV or oral bolus. A continuous IV infusion is reserved for:
- Severe volume overload (>5-10 liters)
- Diuretic resistance (inadequate response to bolus dosing)
- Failure to respond to conventional loop diuretic therapy
Important note: Per the Michigan Medicine inpatient guidelines (2022), IV torsemide is no longer commercially available in the US as an IV formulation. Oral torsemide (with its high ~80% bioavailability) or IV furosemide is the practical alternative in most US settings.
Dosing Table (Braunwald's Heart Disease)
| Clinical Scenario | Route | Torsemide Dose |
|---|
| Moderate overload | IV bolus | 10-20 mg |
| Severe overload | IV bolus | 20-100 mg |
| Severe overload | Continuous infusion | 5-20 mg/hr |
| Refractory to loop diuretics | Continuous infusion | 5-20 mg/hr (titrate) |
- Braunwald's Heart Disease (Table 49.6)
Dose Conversion Reference
When transitioning between agents:
- 40 mg oral furosemide ≈ 20 mg IV furosemide ≈ 20 mg IV or oral torsemide
Torsemide has significantly higher oral bioavailability (~80-100%) vs. furosemide (~40-70%), making oral torsemide a preferred oral option when IV access is not available.
Infusion Protocol (Practical)
- Loading dose: Give an initial IV bolus first (10-20 mg for moderate, 20-100 mg for severe disease)
- Maintenance infusion: Start at 5 mg/hr; titrate upward to 20 mg/hr based on urine output
- Target urine output: Typically 100-200 mL/hr or net negative fluid balance of 1-2 L/day
- Titration: Double the infusion rate if urine output is inadequate after 1-2 hours
- Monitor: Serum Na+, K+, creatinine, BUN, and blood pressure closely
Evidence: Bolus vs. Continuous Infusion
The DOSE trial (N=308, NEJM 2011) found no significant difference in symptom relief or renal function between continuous infusion and twice-daily bolus dosing of furosemide. High-dose strategy (2.5x oral dose) showed greater net fluid loss and dyspnea relief, but more transient creatinine rises. This data was primarily for furosemide; torsemide-specific infusion RCT data is limited.
Furosemide IV Equivalency for Reference
If torsemide IV is unavailable, furosemide infusion is the standard alternative:
- Furosemide infusion: 5-40 mg/hr (severe overload)
- Torsemide to furosemide ratio: 1:2 (20 mg torsemide ≈ 40 mg furosemide)
Bottom line: For torsemide continuous infusion, the standard dose range is 5-20 mg/hr after a loading bolus, titrated to clinical response. Given the limited availability of IV torsemide in many centers, furosemide infusion is the more commonly practiced alternative, with dose adjustment using the 1:2 conversion ratio.